CPhI’s High Potent Drugs conference will bring together international and domestic experts discussing on high potent drug manufacturing and R&D challenges. The conference will be held at The Holiday Inn Mumbai International Airport from January 23 to 25, 2013.
The strategic meet will cover a wide gamut of topics that concern advances in high potent drug development, manufacturing and facility design to ensure swift market introduction of cost-effective and consistent quality high potent drugs. Challenges associated with high potent drug manufacturing like categorisation of potent drugs, regulatory complexities, effective handling of hazardous drugs and waste management will be addressed at this high-level strategic conference along with a workshop on facility design and engineering control requirements for high potent drugs
At High Potent Drugs 2013, senior industry experts such as Justin Mason from Safebridge, Dean Calhoun from Affygility Solutions, Rino Coladangelo from Rephine, Dr Bhaswath Chakraborty from Cadila Pharmaceuticals and Jatin Gajjar from Famy Care will share valuable insights on significant approaches in the high potent drug domain. The event will also bring together presidents, directors, Heads of R&D, manufacturing, formulations and containment equipment from across the globe.
EP News Bureau – Mumbai
